Sun Pharma Establishes Professorship at Mount Sinai

Sun Pharmaceutical Industries Limited has established the Sun Professorship in Dermatology at the Icahn School of Medicine at Mount Sinai, supported by a $2.5 million endowment. This professorship aims to fund academic leadership in dermatology in perpetuity, fostering research, education, and mentorship. Mark G. Lebwohl, M.D., has been installed as the inaugural professor. This initiative underscores Sun Pharma's commitment to advancing dermatologic care through scientific innovation and education, particularly given its position as the second-largest pharmaceutical dermatology company in the U.S. by prescription volume. The endowment will support ongoing advancements in the field and the training of future leaders.